The U.S. patent system is a cornerstone of economic growth and technological advancement, particularly for small businesses, ...

Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

Biosimilars hold the potential to dramatically lower health care costs and improve access to life-changing treatments, but ...

At times, the cycling patent news cycle feels intense and a little relentless. A patent for exciting new components or some ...

China doesn't play by the rules when it comes to intellectual property. Former Congressman Lamar Smith writes that Congress ...

Early indications are that SMEs are embracing the Unitary Patent System and the benefits it offers in terms of cost, ...

Palworld developer Pocket Pair has explained the details of Nintendo's patent infringement lawsuit against it, and the ...

Recently, the Patent Trial and Appeals Board (“PTAB”) released a final written decision finding no challenged claims were unpatentable in ...

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

Connected devices like phones, laptops, tablets, and routers as well as smart homes, smart cars, smart factories, and smart ...